11th Annual IP Forefront Pharma Forum (IFPF): Applying Legacy Statutes to Modern Modalities: Adapting US PTE Law for Complex Biologics

Jean Ge will present “Applying Legacy Statutes to Modern Modalities: Adapting US PTE Law for Complex Biologics” as part of the pre-conference seminar on Patent Term Extension (PTE), Regulatory Data Protection (RDP), and Patent Linkage at the 11th IP Forefront Pharma Forum (IFPF). This forum brings together patent attorneys, in-house IP counsel, and policy experts from more than 20 countries and regions to explore the innovation, protection, and globalization issues shaping pharma IP today.

Jean’s talk will examine how the US PTE framework — written decades ago with small-molecule drugs in mind — applies to today’s complex biologics, including antibody-drug conjugates, antibody-oligonucleotide conjugates, RNA therapeutics, and cell and gene therapies, and how companies can navigate PTE strategy for next-generation biotherapeutics.